SCHEMBL5011693

SCHEMBL5011693

[O]c1nc2c(N3CCN(CCc4ccc(C(F)(F)F)cc4)CC3)cccc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.45
ADRA1B P35368 3/20 0.45
ADRA1D P25100 2/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
MTOR P42345 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HTR1A P08908 12/20 0.44
HTR2C P28335 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5011767 0.87 HRH3 (0.45) ADRA1AADRA1BADRA1DHTR1ADRD2
SCHEMBL2095907 0.84 MAOB (0.44) HRH3
SCHEMBL5016310 0.81 HRH3 (0.48) ADRA1AADRA1BHTR1AHTR2CDRD2
SCHEMBL5012719 0.81 HRH1 (0.49) ADRA1AADRA1BHTR1AHTR2CDRD2
SCHEMBL27644453 0.80 SIGMAR1 (0.47) ADRA1AADRA1BADRA1DALDH1A1CYP1A2
SCHEMBL5011646 0.80 HRH1 (0.48) ADRA1AADRA1BHTR1AHTR2CDRD2
SCHEMBL5013338 0.80 HRH1 (0.48) ADRA1AADRA1BHTR1AHTR2CDRD2
SCHEMBL5012696 0.76 SIGMAR1 (0.46) ADRA1AADRA1BADRA1DHTR1AHTR2C
SCHEMBL5013459 0.73 MEN1 (0.52) ADRA1AADRA1BADRA1DALDH1A1HTR1A
SCHEMBL5013346 0.73 KDM4E (0.45) ALDH1A1MAPTTSHRMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed